Eicosanoids and lung macrophage antimicrobial mechanisms
类二十烷酸和肺巨噬细胞抗菌机制
基本信息
- 批准号:7668216
- 负责人:
- 金额:$ 38.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-10 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerol1-Phosphatidylinositol 3-Kinase1-Phosphatidylinositol 4-KinaseAbbreviationsAddressAdenylate CyclaseAlveolarAlveolar MacrophagesArachidonate 5-LipoxygenaseArachidonic AcidsAttentionBindingBiologicalCREB1 geneCategoriesCell surfaceCellsCharacteristicsCholesterolChromosomesChromosomes, Human, Pair 10ClassCouplingCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Responsive DNA-Binding ProteinCyclodextrinsDataDevelopmentDiglyceridesDinoprostoneDiseaseDistalEicosanoid ReceptorEicosanoidsErythrocytesEventFamilyFc ReceptorFigs - dietaryFluorescence Resonance Energy TransferFundingG-Protein-Coupled ReceptorsGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsGuanosineGuanosine Triphosphate PhosphohydrolasesHealthHost DefenseImmuneImmune responseImmunoglobulin GImmunologicsInfectionIngestionInositol PhosphatesLTB4R geneLeukotriene B4Leukotriene D4Leukotriene ReceptorLeukotrienesLigationLungMediatingMembrane MicrodomainsMicrobeMolecularMonomeric GTP-Binding ProteinsNatural ImmunityOrganPTEN genePathway interactionsPertussis ToxinPhagocytesPhagocytosisPhosphatidylinositol PhosphatesPhosphatidylinositolsPhospholipase CPhosphoric Monoester HydrolasesPhosphotransferasesProcessProstaglandin-Endoperoxide SynthaseProstaglandinsProtein IsoformsProtein Kinase CProteinsRattusReceptor SignalingRegulationRoleSecond Messenger SystemsSheepSignal PathwaySignal TransductionTestingTyrosineabstractinganalogantimicrobialarachidonatecitrate carrierclinically relevantcyclooxygenase 1cyclooxygenase 2cysteinyl leukotriene receptorcysteinyl-leukotrienehuman WFDC2 proteinimmune functioninhibitor/antagonistinsightkillingslipid mediatormacrophageneutrophilopsonin receptorphosphatidylinositol phosphatereceptorrhosecond messengersmall hairpin RNA
项目摘要
Project Summary/Abstract:
Infections of the lung have a greater impact on global health than any other category of disease, and
there is an urgent need to better understand antimicrobial defense of the lung. Alveolar macrophages (AMs)
are the resident innate immune defenders of the distal lung, and the immunologic repertoire of these cells often
differs substantially from that of other phagocytic cells. Among the substances elaborated during infection,
lipid mediators derived from arachidonate (eicosanoids), including leukotrienes (LTs) B4 (LTB4) and D4 (LTD4)
as well as prostaglandin E2 (PGE2), have emerged as important modulators of innate immune function.
Eicosanoids act by ligating specific G protein-coupled receptors on the cell surface and initiating signaling
events. We have shown that both LTBB4 (via B LT receptor 1 [BLT1]) and LTD4 (via cysteinyl LT receptor 1
[cysLT1]) promote, while PGE2 (via E prostanoid receptors 2 and 4 [EP2 and EP4]) inhibits, AM capacity for
phagocytosis and killing of IgG-opsonized microbes. However, the intracellular mechanisms by which these
eicosanoids act are incompletely understood. Although both LT classes promote innate immune functions in
AMs, they act via distinct signaling pathways. Likewise, suppression of AM innate immune functions following
ligation of EP2 and EP4 is mediated by distinct pathways. As development of pharmacologic agents targeting
specific eicosanoid receptors is proceeding rapidly, it is important that the effects of such targeted therapies on
antimicrobial defenses of the lung are understood. This project seeks to understand the mechanisms by which
these eicosanoids influence key events in the AM signaling pathway triggered by the receptor for opsonic IgG
¿ the Fc? receptor (FcR). The central signaling events we will focus on are activation of: 1) phosphoinositide 3-
kinase (PI3K)/phosphatase and tensin homolog deleted on chromosome 10 (PTEN); 2) isoforms of protein
kinase C (PKC); and 3) small GTPases. The hypothesis is that divergent effects on these FcR-triggered
signaling components by ligation of BLT1 vs. cysLT1 and EP2 vs. EP4 reflect the differential localization of
these receptors to lipid raft membrane microdomains and their differential coupling to two distinct cyclic AMP
effectors ¿ protein kinase A (PKA) and exchange protein activated by cyclic AMP (Epac-1). Employing primary
rat AMs, we will address specific aims to determine: 1) regulation by PKA and Epac-1 of FcR-induced signaling
events; 2) localization to lipid rafts of FcR and its downstream signaling components and the role of rafts in
phagocytosis and killing; 3) the roles of PKA vs. Epac-1 and of lipid raft localization in explaining divergent
modulation of FcR signaling by BLT1 vs. cysLT1 ligation; 4) the roles of PKA vs. Epac-1 and of lipid raft
localization in explaining divergent modulation of FcR signaling by EP2 vs. EP4 ligation. These proposed
studies will provide fundamental insights into AM antimicrobial function, and a clinically relevant framework for
understanding and modulating innate immunity in the lung.
项目摘要/摘要:
肺部感染对全球健康的影响比任何其他类别的疾病都更大,并且
迫切需要更好地了解肺部的抗菌防御。肺泡巨噬细胞(AMS)
居民是远端肺的先天免疫防御者,并且这些细胞的免疫学曲目经常
与其他吞噬细胞不同。在感染过程中阐述的物质中
源自蛛网膜(Eicosanoids)的脂质介质,包括白细胞(LTS)B4(LTB4)和D4(LTD4)
以及前列腺素E2(PGE2)以及先天免疫功能的重要调节剂。
类eicosanoids通过在细胞表面连接特定的G蛋白偶联受体并启动信号传导作用
事件。我们已经表明LTBB4(通过B LT受体1 [BLT1])和LTD4(通过Cysteinyl LT受体1
[Cyslt1])促进,而PGE2(通过E前列腺素受体2和4 [EP2和EP4])抑制AM的能力
吞噬作用和IgG开放式微生物的杀戮。但是,这些细胞内机制
类osanoids法案尚未完全理解。尽管这两个LT类都促进了先天免疫功能
AMS,它们通过不同的信号通路起作用。同样,抑制AM先天免疫功能之后
EP2和EP4的连接是由不同的途径介导的。作为靶向药理剂的开发
特定的类素受体正在迅速进行,重要的是,这种靶向疗法对
了解肺的抗菌防御能力。该项目旨在了解该项目的机制
这些类固醇会影响接收器opsonic IgG触发的AM信号传导途径中的关键事件
FC?受体(FCR)。我们将重点关注的中心信号事件是激活:1)磷酸肌醇3--
激酶(PI3K)/磷酸酶和Tensin同源物在10(PTEN)上删除; 2)蛋白质的同工型
激酶C(PKC); 3)小gtpase。假设是对这些FCR触发的不同影响
通过BLT1与Cyslt1和EP2与EP4的连接来传导成分
这些受体到脂质筏膜微区及其差异耦合到两个不同的环状AMP
效应子 - 蛋白激酶A(PKA)和通过环状AMP激活(EPAC-1)激活的蛋白质。雇用主要
大鼠AMS,我们将解决确定的特定目的:1)通过PKA和EPAC-1对FCR诱导的信号传导进行调节
事件; 2)定位于FCR的脂质筏及其下游信号传导成分以及筏在
吞噬作用和杀戮; 3)PKA与EPAC-1和脂质筏定位的作用在解释不同
通过BLT1与Cyslt1连接对FCR信号的调节; 4)PKA与EPAC-1和脂质筏的作用
通过EP2与EP4连接解释FCR信号传导的分歧调制的定位。这些提议
研究将提供对AM抗菌功能的基本见解,并为临床相关的框架
理解和调节肺中的先天免疫力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC L PETERS-GOLDEN其他文献
MARC L PETERS-GOLDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC L PETERS-GOLDEN', 18)}}的其他基金
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
9900069 - 财政年份:2019
- 资助金额:
$ 38.3万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10561635 - 财政年份:2019
- 资助金额:
$ 38.3万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10352439 - 财政年份:2019
- 资助金额:
$ 38.3万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10112297 - 财政年份:2019
- 资助金额:
$ 38.3万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
9103201 - 财政年份:2015
- 资助金额:
$ 38.3万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
9257198 - 财政年份:2015
- 资助金额:
$ 38.3万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
8961063 - 财政年份:2015
- 资助金额:
$ 38.3万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
7728502 - 财政年份:2009
- 资助金额:
$ 38.3万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8294649 - 财政年份:2009
- 资助金额:
$ 38.3万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
7910714 - 财政年份:2009
- 资助金额:
$ 38.3万 - 项目类别:
相似海外基金
Reactive nitrogen species and accelerated atherosclerosis
活性氮和加速动脉粥样硬化
- 批准号:
7279125 - 财政年份:2004
- 资助金额:
$ 38.3万 - 项目类别:
Phosphoinositide-calcium Signaling In Cell Regulation
细胞调节中的磷酸肌醇-钙信号转导
- 批准号:
7594120 - 财政年份:
- 资助金额:
$ 38.3万 - 项目类别: